Get the Stockscreener App
0.6879
0.52%
-0.0036
After Hours:
.68
-0.0079
-1.15%
Bioatla Inc stock is traded at $0.6879, with a volume of 498.68K.
It is down -0.52% in the last 24 hours and up +51.02% over the past month.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
See More
Previous Close:
$0.6915
Open:
$0.698
24h Volume:
498.68K
Relative Volume:
0.65
Market Cap:
$40.39M
Revenue:
-
Net Income/Loss:
$-123.46M
P/E Ratio:
-0.2656
EPS:
-2.59
Net Cash Flow:
$-104.11M
1W Performance:
+18.66%
1M Performance:
+51.02%
6M Performance:
+98.36%
1Y Performance:
-60.91%
1-Day Range:
$0.6712
$0.7499
1-Week Range:
$0.5751
$0.75
52-Week Range:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Name
Bioatla Inc
Sector
Industry
Phone
858-558-0708
Address
11085 TORREYANA ROAD, SAN DIEGO
Compare BCAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.6879 | 40.61M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Nov-13-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-15-22 | Initiated | JMP Securities | Mkt Outperform |
| May-05-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-21-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Jun-28-21 | Initiated | ROTH Capital | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | BTIG Research | Buy |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | JP Morgan | Overweight |
| Jan-11-21 | Initiated | Jefferies | Buy |
View All
Bioatla Inc Stock (BCAB) Latest News
Should you wait for a breakout in BioAtla Inc.July 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
Will BioAtla Inc. stock keep outperforming rivalsEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Real time alert setup for BioAtla Inc. performance2025 Volatility Report & Precise Swing Trade Entry Alerts - newser.com
Can momentum traders help lift BioAtla Inc.July 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Detecting price anomalies in BioAtla Inc. with AIWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com
Can technical indicators confirm BioAtla Inc.’s reversalTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Why BioAtla Inc. stock could outperform in 2025Earnings Recap Summary & Risk Managed Investment Entry Signals - newser.com
Historical volatility pattern of BioAtla Inc. visualizedForecast Cut & Long Hold Capital Preservation Tips - newser.com
How to track smart money flows in BioAtla Inc.Index Update & Precise Buy Zone Tips - newser.com
Why BioAtla Inc. stock is rated strong buyWeekly Risk Summary & Daily Oversold Bounce Ideas - newser.com
Will BioAtla Inc. stock recover after recent drop2025 Trading Volume Trends & Daily Stock Trend Watchlist - newser.com
What drives BioAtla Inc stock priceUtilities Sector Analysis & Free Daily Market Summary and Trend Reports - earlytimes.in
What analysts say about BioAtla Inc stockStock Market Trends & Learn What Analysts Rate “Strong Buy” - earlytimes.in
What MACD signals say about BioAtla Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Real time social sentiment graph for BioAtla Inc.Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
Bioatla Inc Stock (BCAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):